Aberdeen Group’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.04M Buy
982,527
+515,144
+110% +$1.59M 0.01% 749
2025
Q1
$1.63M Buy
+467,383
New +$1.63M ﹤0.01% 775